Acute Q fever related in-hospital mortality in the Netherlands von Kampschreur, L M, Wegdam-Blans, M C A, Thijsen, S F T, Groot, C A R, Schneeberger, P M, Hollander, A A M J, Schijen, J H E M, Arents, N L A, Oosterheert, J J, Wever, P C

Volltext

Endovascular stenting in neoplastic superior vena cava syndrome prior to chemotherapy or radiotherapy von BIERDRAGER, E, LAMPMANN, L. E. H, LOHLE, P. N. M, SCHOEMAKER, C. M, SCHIJEN, J. H. E. M, PALMEN, F. M. L. H. G, VAN DER HEUL, C

Volltext

LBA92Switch maintenance gemcitabine after first-line chemotherapy in patients with malignant mesothelioma: A multicenter open label phase II trial (NVALT19) von Burgers, S A, de Gooijer, C, Cornelissen, R, Aerts, J G, Biesma, B, Heemst, R V, Youssef-El Soud, M, Groen, H J M, Staal-van den Brekel, A J, Bootsma, G, Schijen, J H E M, Baas, P, Giovannetti, E, de Vries, J F, Hogenboom, F A, de Wit, D C M, Mahn- Schaefers, M C W, Lalezari, F, van de Noort, V, Stigt, J

Volltext

Switch maintenance gemcitabine after first-line chemotherapy in patients with malignant mesothelioma: A multicenter open label phase II trial (NVALT19) von Burgers, S.A., de Gooijer, C., Cornelissen, R., Aerts, J.G., Biesma, B., Heemst, R.V., Youssef-El Soud, M., Groen, H.J.M., Staal-van den Brekel, A.J., Bootsma, G., Schijen, J H E M, Baas, P., Giovannetti, E., de Vries, J.F., Hogenboom, F.A., de Wit, D.C.M., Mahn- Schaefers, M.C.W., Lalezari, F., van de Noort, V., Stigt, J.

Volltext

LBA92 - Switch maintenance gemcitabine after first-line chemotherapy in patients with malignant mesothelioma: A multicenter open label phase II trial (NVALT19) von Burgers, S.A., de Gooijer, C., Cornelissen, R., Aerts, J.G., Biesma, B., Heemst, R.V., Youssef-El Soud, M., Groen, H.J.M., Staal-van den Brekel, A.J., Bootsma, G., Schijen, J H E M, Baas, P., Giovannetti, E., de Vries, J.F., Hogenboom, F.A., de Wit, D.C.M., Mahn- Schaefers, M.C.W., Lalezari, F., van de Noort, V., Stigt, J.

Volltext